These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26933912)

  • 1. Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.
    Kong J; Di C; Piao J; Sun J; Han L; Chen L; Yan G; Lin Z
    Oncotarget; 2016 Apr; 7(15):19631-42. PubMed ID: 26933912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells].
    Tian T; Hua Z; Wang LZ; Wang XY; Chen HY; Liu ZH; Cui ZM
    Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):99-105. PubMed ID: 29534378
    [No Abstract]   [Full Text] [Related]  

  • 4. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
    Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
    Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
    Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K
    Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer.
    Zacapala-Gómez AE; Navarro-Tito N; Alarcón-Romero LDC; Ortuño-Pineda C; Illades-Aguiar B; Castañeda-Saucedo E; Ortiz-Ortiz J; Garibay-Cerdenares OL; Jiménez-López MA; Mendoza-Catalán MA
    BMC Cancer; 2018 Mar; 18(1):349. PubMed ID: 29587669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
    Chen X; Lan K; Liu Q; Yang X; Wang H
    Tumour Biol; 2017 Mar; 39(3):1010428317695942. PubMed ID: 28351308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt/Ezrin Tyr353/NF-κB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma.
    Wang Y; Lin Z; Sun L; Fan S; Huang Z; Zhang D; Yang Z; Li J; Chen W
    Br J Cancer; 2014 Feb; 110(3):695-705. PubMed ID: 24346284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition.
    Liu M; Liu J; Yang B; Gao X; Gao LL; Kong QY; Zhang P; Li H
    Anat Rec (Hoboken); 2017 Dec; 300(12):2184-2191. PubMed ID: 28921916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
    Miao JW; Liu LJ; Huang J
    Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
    Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
    Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.
    Gong P; Wang Y; Gao Y; Gao M; Liu L; Qu P; Jin X; Gao Q
    Hum Pathol; 2017 Jul; 65():53-61. PubMed ID: 28088346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of ezrin predicts poor prognosis in uterine cervical cancer.
    Kong J; Li Y; Liu S; Jin H; Shang Y; Quan C; Li Y; Lin Z
    BMC Cancer; 2013 Nov; 13():520. PubMed ID: 24182314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
    Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
    Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition.
    Zhou Y; Huang Y; Cao X; Xu J; Zhang L; Wang J; Huang L; Huang S; Yuan L; Jia W; Yu X; Luo R; Zheng M
    PLoS One; 2016; 11(8):e0160414. PubMed ID: 27513465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of Ezrin inhibited migration and invasion of cervical cancer cells in vitro.
    Xi M; Tang W
    Int J Immunopathol Pharmacol; 2020; 34():2058738420930899. PubMed ID: 32674647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.